Tumor-Immune Crosstalk

• 4976 · PDF Upregulation of a B7 family protein drives immune escape in therapy-induced senescent cancer cells Donghee Kang, Min-Ji Kim, Hyung Jung Hwang, Jeong Minwoo, Jong-Ho Cha, Jae-Seon Lee
• 4977 · PDF Programmed cell death ligand 1 (PD-L1) expression across molecular subtypes of human high-grade ductal carcinoma in situ (DCIS) of the breast Hossein Schandiz, Lorant Farkas, Berit Gravdehaug, Elin Edda Seland Agustsdottir, Torill Sauer, Jürgen Geisler
• 4978 · PDF MHC class 1 expression and distribution of multiple immune cells in chemotherapy-naïve triple-negative breast cancers: lack of antigen-presentation can bring high TILs and good prognosis, possibly via decreased regulatory T-cell composition Makiko Yamashita, Akira I. Hida, Naomi Gondo, Yasuyo Ohi, Shigehisa Kitano
• 4979 · PDF CD155- binding peptide enhances antitumor activity of T cells and cytotoxic activity of a lytic peptide in colon tumor Gunassekaran Gowri Rangaswamy, Poongkavithai Vadevoo Sri Murugan, Byungheon Lee
• 4980 · PDF Clinical and prognostic significance of spatial distribution of CD163-positive tumor-associated macrophages in pleural mesothelioma Ryota Sumitomo, Tetsuya Fukui, Masashi Kobayashi, Hiroaki Sakai, Toshi Menju
• 4981 New thought and strategy of liver cancer immunotherapy Gen-Sheng Feng
• 4982 · PDF Targeting collagen receptor CD49b enhances PD-L1 blockade by promoting CD8⁺ T-cell immunity in breast cancer Ibrahim R. Eissa, Kenneth K. Tanabe
• 4984 · PDF Dissociative, spatial, and functional single-cell profiling reveals antigen-driven exhaustion and chemotactic failure of tumor-reactive T cells in HPV-negative HNSCC Joseph Zenga, Musaddiq Awan, Fumou Sun, Stuart J. Wong, Abdullah Memon, Tyce Kearl, Ean Norenberg, Margaret L. Hoang, Joseph M. Beechem, Eric Hobbs, Ashley Heck, Rachel Liu, Daniel McGuire, Erin Piazza, Peiman Hematti, Heather Himburg
• 4985 · PDF The role of CD5L in regulating liver immune cells Diala S. Alhousari, Handan Hong, Taojian Tu, Bangyan L. Stiles
• 4986 · PDF Identification of tumor microenvironment for high infiltration of lymphocytes in triple negative breast cancer Sowon Choi, Hee Jin Lee, Byung-Kwan Jeong, Hyun Je Kim
• 4987 · PDF Dual roles of JNK1 and JNK2 in TNBC progression and tumor microenvironment immune modulation reveal a novel therapeutic vulnerability Bharat Singh Kuntal, Xuemei Xie, Xanthe stern, Kendall Nakaoka, Marilisa Fujimoto, Marisa William, Madixx Muramoto, Naoto T. Ueno
• 4988 · PDF Comprehensive tumor microenvironment analysis identifies a suppressive immune landscape in stemness-high hepatocellular carcinoma Woo Young Kwon, Sungho Ko, Sungwoo Cho, Song-A Park, Sihun Cho, Sung Hwan Lee
• 4990 · PDF Single-cell mass cytometry reveals T-cell exhaustion in sentinel nodes of ER+ breast cancer without histological detectable metastases Inga Hansine Rye, Marit Otterlei FJørtoft, Karin Teien Lande, Margit Riis, Ole Christian lingjærde, Øystein Garred, Colin LaMont, June Myklebust, Kanutte Huse, Hege Russnes
• 4991 · PDF Stromal MAOB promotes prostate cancer growth by suppressing antitumor immunity Jing Wei, Hsiang Ching Huang, Kaisheng Yuan, Alivia O'Brien, Boyang Wu
• 4992 · PDF Activin A promotes PDAC progression via immunosuppression and non-canonical signaling Mark B. Wiley, Jessica Bauer, Yuchen Wang, Barbara Jung
• 4993 · PDF Tumor-associated macrophages promote oral squamous cell carcinoma development Manlin Shao, Carlos Caulin
• 4994 · PDF Exosome-targeted xmot-shRNA as a modular platform to dissect signaling pathways driving tolerogenic dendritic cells in the tumor microenvironment Mahere Rezazade Bazaz, Michael P. Plebanek, Y-Van Nguyen, Xueying Wang, Balamayooran Theivanthiran, Brent A. Hanks
• 4995 · PDF LAMP3+ migratory dendritic cells establish immune-accessible tumor microenvironment in non-Hodgkin lymphoma Yulong Wei, David Alexander Braun, Ya-Chi Ho
• 4996 · PDF Biomarker discovery and the targeting of tumor immune suppression in Renal Cell Carcinoma Giuliana P. Mognol, Erpei Wang, William Harris, Tami Von Schalscha, Birkley S. Lim, Rayan Jouny, Ahmed Abdelhak, Rana R. McKay, Judith Varner
• 4997 · PDF TME profiling in Colombian men with suspected prostate cancer Dayanne M. Rodríguez Hernández, Jovanny Zabaleta, Luis D Valle, Rafael Parra-Medina, Carmen L. Roa, Alvaro Gutierrez, Mateo Barros Barraza, Alba Lucía Cómbita
• 4998 · PDF ImmunoPET imaging of human tumor associated macrophages Ayla Vaughn Embs, Borna Roohani, Robin Kumar, Dajah Nash, Chloe La Prairie, Mann Dangarwala, Harriet M. Kluger, Ping Zhang, Benjamin Larimer, Bernadette V. Marquez-Nostra
• 4999 · PDF GFRAL is not required for PDAC tumor development and TME immune cell suppression Emma Crockett Funk, Abasi-ama Udeme, Cynthia F. Wright, Jenna Schwesig, Michael C. Ostrowski, Teresa A. Zimmers, Leonidas G. Koniaris, David Wang, Denis C. Guttridge
• 5000 · PDF Activin receptor subtype-2A regulates innate immune cell activation and non-canonical signaling in pancreatic cancer cells Yuchen Wang, Mark B. Wiley, Jessica Bauer, Xinru Wang, Jordi Guillem-Marti, David Lee, David Baker, Barbara Jung
• 5001 · PDF Dynamics of HER2-driven MHC I immune evasion utilizing PWK x NeuT mice Ryann Ray, Hui-En Chou, WEI-ZEN WEI, Jennifer Jacob
• 5002 · PDF Notch4 blockade reprograms tumor-associated macrophages and enhances anti-tumor inflammatory signature in breast cancer Katherine A. Alexander, Jason Eng, Yu Kato, Bhairavi Swaminathan, Debdutta Mandal, Yajath Narra, L. A. Naiche, Yasuhiro Funahashi, Junji Matsui, Jan Kitajewski
• 5003 · PDF Treg-specific inhibition of hedgehog signaling alters their function and impedes the growth of murine triple-negative breast cancer Ian Miranda, Courtney Swain, Brandon J. Metge, Lalita Shevde

在完整检索应用中浏览本分会场 →